Normal
10th - 11th March 2022

6th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress- UK

ILEC Conference Center and IBIS London Earls Court, 47 Lillie Road, London, SW6 1UD

The treatment options for cancer, such as chemotherapies and radiation therapy, although have more side effects, are more widely used as compared to immunotherapies. The former are all based on destroying cancer cells by irradiation, chemotherapy, or surgery. While they can effectively kill or remove cancer cells, the use of these treatments is often limited because they tend to destroy healthy cells in large numbers as well. As immunotherapies involve the mechanism of enhancing the body’s own immunity using man-made proteins such as monoclonal antibodies, they are accepted worldwide over other treatment options.

Our 6th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress to be held on 10th-11th March 2022 in London, UK would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.

WHAT TO EXPECT

Key Highlights

  • Updates in development of ADC’s and Bispecific Ab’s
  • Immune Checkpoint Inhibitors and Combinations
  • Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
  • Biomarkers and Personalized Medicine in IO
  • CAR-T Cell therapy, TCR Based-Cell Therapy
  • Tumor microenvironment
  • Oncolytic Viruses
  • Personalized Cancer Immunotherapy

Who Should Attend?

CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group Leaders, Professors, Assistant Professors, Research fellows, PhDs working on

  • Monoclonal and Bispecific Antibodies
  • Cell Therapy
  • Immune Checkpoint Inhibitors

Why attend?

  • Exclusive conference to learn about antibodies, cellular therapy and immune-checkpoint research under one roof
  • Find out new case studies of immune-oncology projects in development
  • Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you
  • Explore the latest platforms and technologies on the market for development
  • Discuss the best tool for your research in immune-oncology
  • Share your work and achievements with your industry peers in the Poster Session

CONFERENCE AGENDA
NEW ANTIBODY FORMATS & CELLULAR THERAPY
NEW IMMUNE CHECKPOINTS, BIOMARKER AND TUMOUR MICROENVIRONMENT
CONFERENCE SPEAKERS
Speakers
Andrew Sewell
Andrew Sewell
Distinguished Research Professor and Wellcome Trust Senior Investigator,, Cardiff University
Corinne Danan
Corinne Danan
General Manager, Biopharma, Veracyte
Mireille Vankemmelbeke
Mireille Vankemmelbeke
Principle Scientist, Scancell
Brian Keppler
Brian Keppler
Director, Discovery and Translational Sciences, Metabolon
Sebastien Tabruyn
Sebastien Tabruyn
Chief Scientific Officer, Transcure Bioservices
Jessica McDonough
Jessica McDonough
Co-Founder, Attivare Therapeutics
Matthew Cashmore
Matthew Cashmore
Senior Product Specialist, Epredia
Hannaneh Davatgar
Hannaneh Davatgar
Senior Product Specialist, Epredia
SPONSORS
Gold
example-image

Thermo Fisher Scientific

example-image

Proteome Sciences

example-image

Personalis

Silver
example-image

PHC Group

example-image

Epredia

example-image

Lonza

Speaking Partner
example-image

Kiromic Biopharma

example-image

TransCure bioServices

example-image

QIAGEN

example-image

Veracyte

example-image

Metabolon

Exhibition Partner
example-image

Champions Oncology

example-image

Myriad RBM

example-image

Proteintech

example-image

Concept Life Sciences

example-image

Angle Plc

Meeting Partner
example-image

Larvol

PARTNERS
Supporting Association
MabDesign

MabDesign

One Nucleus

One Nucleus

Media Partners
example-image

Bentham Science

LOCATION
ILEC Conference Center and IBIS London Earls Court, 47 Lillie Road, London, SW6 1UD
About the Hotel

PAST EVENT GALLERY